| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 21.488 | 43.891 | 58.252 | 66.498 | 75.971 |
| Total Income - EUR | - | - | - | - | - | 21.523 | 43.898 | 58.524 | 66.895 | 77.201 |
| Total Expenses - EUR | - | - | - | - | - | 7.079 | 17.773 | 23.851 | 21.078 | 17.887 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 14.444 | 26.126 | 34.672 | 45.817 | 59.314 |
| Net Profit/Loss - EUR | - | - | - | - | - | 13.841 | 24.835 | 33.675 | 45.162 | 57.162 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bona Fide Duo Doctors S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 6 | 530 | 332 | 133 | 72 |
| Current Assets | - | - | - | - | - | 14.347 | 24.747 | 34.531 | 45.936 | 59.423 |
| Inventories | - | - | - | - | - | 151 | 0 | 67 | 0 | 0 |
| Receivables | - | - | - | - | - | 2.578 | 3.869 | 22.448 | 0 | 40.259 |
| Cash | - | - | - | - | - | 11.619 | 20.878 | 12.016 | 45.936 | 19.165 |
| Shareholders Funds | - | - | - | - | - | 13.882 | 24.884 | 33.724 | 45.210 | 57.211 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 471 | 499 | 1.221 | 956 | 2.414 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bona Fide Duo Doctors S.r.l.